Cambridge, MA, United States of America

James Angstman

USPTO Granted Patents = 9 

 

Average Co-Inventor Count = 3.7

ph-index = 4

Forward Citations = 147(Granted Patents)


Location History:

  • Boston, MA (US) (2018)
  • Cambridge, MA (US) (2018 - 2021)
  • Charlestown, MA (US) (2020 - 2024)

Company Filing History:


Years Active: 2018-2025

Loading Chart...
Loading Chart...
9 patents (USPTO):Explore Patents

Title: The Innovative Mind of James Angstman: Revolutionizing Genetic Repair

Introduction

James Angstman, a prominent inventor based in Cambridge, Massachusetts, has made significant contributions to the field of genetic engineering with a total of nine patents to his name. His innovative work focuses on enhancing the efficiency of gene editing techniques, particularly in the realm of homology-directed repair (HDR), which holds great potential for advancements in genetic therapies.

Latest Patents

Two of James Angstman’s latest patents showcase his groundbreaking approach to improving HDR techniques. The first patent, titled "Methods for Increasing Efficiency of Nuclease-Induced Homology-Directed Repair," describes innovative methods to enhance the absolute and relative rates of HDR compared to non-homologous end joining (NHEJ). This work aims to streamline genetic repairs, opening new avenues for medical treatments.

The second patent, "TAL-Tet1 Fusion Proteins and Methods of Use Thereof," focuses on the development of fusion proteins that combine a DNA-binding domain, such as a TAL effector repeat array, with a catalytic domain capable of hydroxylating methylated cytosines in DNA. This technological advancement could significantly improve the precision of genetic modifications.

Career Highlights

Currently, James Angstman is affiliated with The General Hospital Corporation, where he applies his extensive knowledge in genetics and molecular biology to create transformative healthcare solutions. His work is instrumental in positioning the organization as a leader in innovative health technologies.

Collaborations

Throughout his career, Angstman has collaborated with esteemed colleagues, including J. Keith Joung and Morgan Maeder. Together, they have pushed the boundaries of genetic research, fostering an environment of innovation and discovery.

Conclusion

James Angstman's contributions to genetic engineering through his patented inventions illustrate his commitment to enhancing the efficiency of crucial genetic repair methods. His work not only advances scientific understanding but also paves the way for future breakthroughs in medical treatment and genetic therapies. With an impressive portfolio of patents and valuable collaborations, Angstman continues to be a driving force in the field of innovation.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…